Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Sep;33(9):2353–2357. doi: 10.1128/jcm.33.9.2353-2357.1995

Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing.

K Ouchi 1, M Abe 1, M Karita 1, T Oguri 1, J Igari 1, T Nakazawa 1
PMCID: PMC228411  PMID: 7494027

Abstract

We analyzed strains of Burkholderia (formerly Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing methods. One hundred isolates of B. cepacia were obtained from patients at several wards in a single hospital from March 1983 to February 1984. These isolates were classified into 12 groups by a new biochemical typing scheme on the basis of the production of six enzymes and the production of hemolytic substance and yellow pigment. Among them, 33 strains collected from the 12 groups were further characterized by DNA fingerprinting by pulse-field gel electrophoresis, ribotyping, and plasmid profile analysis. Forty-seven strains of B. cepacia of independent origins and 25 isolates from the same hospital obtained 10 years later for a follow-up study were also subjected to analysis. Both DNA fingerprinting and ribotyping clearly discriminated the isolates from different hospitals. Of interest, although the biochemical typing and plasmid profiles of the isolates obtained during 1983 to 1984 in a single hospital were variable, genomic typing identified the majority of the isolates (32 of 33 [97%]) as derivatives of a single strain. Furthermore, a follow-up study suggested the persistence of such derivatives among the isolates after a decade. These results clearly indicated that the outbreak of B. cepacia infection in the hospital was nosocomial in origin. Thus, the usefulness of genomic typing for epidemiological studies of B. cepacia infection was further demonstrated. The biochemical typing revealed the marked variability of phenotypes of B. cepacia.

Full Text

The Full Text of this article is available as a PDF (454.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Nakazawa T. Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia. Microbiol Immunol. 1994;38(1):1–9. doi: 10.1111/j.1348-0421.1994.tb01737.x. [DOI] [PubMed] [Google Scholar]
  2. Anderson D. J., Kuhns J. S., Vasil M. L., Gerding D. N., Janoff E. N. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol. 1991 Mar;29(3):648–649. doi: 10.1128/jcm.29.3.648-649.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ederer G. M., Matsen J. M. Colonization and infection with Pseudomonas cepacia. J Infect Dis. 1972 Jun;125(6):613–618. doi: 10.1093/infdis/125.6.613. [DOI] [PubMed] [Google Scholar]
  4. Gaffney T. D., Lessie T. G. Insertion-sequence-dependent rearrangements of Pseudomonas cepacia plasmid pTGL1. J Bacteriol. 1987 Jan;169(1):224–230. doi: 10.1128/jb.169.1.224-230.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Govan J. R., Harris G. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J Clin Microbiol. 1985 Oct;22(4):490–494. doi: 10.1128/jcm.22.4.490-494.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Heidt A., Monteil H., Richard C. O and H serotyping of Pseudomonas cepacia. J Clin Microbiol. 1983 Sep;18(3):738–740. doi: 10.1128/jcm.18.3.738-740.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kado C. I., Liu S. T. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol. 1981 Mar;145(3):1365–1373. doi: 10.1128/jb.145.3.1365-1373.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kostman J. R., Edlind T. D., LiPuma J. J., Stull T. L. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol. 1992 Aug;30(8):2084–2087. doi: 10.1128/jcm.30.8.2084-2087.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Larsen G. Y., Stull T. L., Burns J. L. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol. 1993 Apr;31(4):788–792. doi: 10.1128/jcm.31.4.788-792.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mukwaya G. M., Welch D. F. Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol. 1989 Dec;27(12):2640–2646. doi: 10.1128/jcm.27.12.2640-2646.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nakazawa T., Yamada Y., Ishibashi M. Characterization of hemolysin in extracellular products of Pseudomonas cepacia. J Clin Microbiol. 1987 Feb;25(2):195–198. doi: 10.1128/jcm.25.2.195-198.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rabkin C. S., Jarvis W. R., Anderson R. L., Govan J., Klinger J., LiPuma J., Martone W. J., Monteil H., Richard C., Shigeta S. Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis. 1989 Jul-Aug;11(4):600–607. doi: 10.1093/clinids/11.4.600. [DOI] [PubMed] [Google Scholar]
  13. Rutala W. A., Weber D. J., Thomann C. A., John J. F., Saviteer S. M., Sarubbi F. A. An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. J Thorac Cardiovasc Surg. 1988 Jul;96(1):157–161. [PubMed] [Google Scholar]
  14. Sobel J. D., Hashman N., Reinherz G., Merzbach D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med. 1982 Aug;73(2):183–186. doi: 10.1016/0002-9343(82)90176-0. [DOI] [PubMed] [Google Scholar]
  15. Sokol P. A., Luan M. Z., Storey D. G., Thirukkumaran P. Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements. J Bacteriol. 1994 Feb;176(3):553–562. doi: 10.1128/jb.176.3.553-562.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stull T. L., LiPuma J. J., Edlind T. D. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Dis. 1988 Feb;157(2):280–286. doi: 10.1093/infdis/157.2.280. [DOI] [PubMed] [Google Scholar]
  17. Tablan O. C., Martone W. J., Doershuk C. F., Stern R. C., Thomassen M. J., Klinger J. D., White J. W., Carson L. A., Jarvis W. R. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest. 1987 Apr;91(4):527–532. doi: 10.1378/chest.91.4.527. [DOI] [PubMed] [Google Scholar]
  18. Takigawa K., Fujita J., Negayama K., Yamagishi Y., Yamaji Y., Ouchi K., Yamada K., Abe M., Nakazawa T., Kawanishi K. Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with contaminated nebulizer devices. Kansenshogaku Zasshi. 1993 Nov;67(11):1115–1125. doi: 10.11150/kansenshogakuzasshi1970.67.1115. [DOI] [PubMed] [Google Scholar]
  19. Vasil M. L., Krieg D. P., Kuhns J. S., Ogle J. W., Shortridge V. D., Ostroff R. M., Vasil A. I. Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect Immun. 1990 Dec;58(12):4020–4029. doi: 10.1128/iai.58.12.4020-4029.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yabuuchi E., Kosako Y., Oyaizu H., Yano I., Hotta H., Hashimoto Y., Ezaki T., Arakawa M. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol. 1992;36(12):1251–1275. doi: 10.1111/j.1348-0421.1992.tb02129.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES